Intra-Cellular Therapies Shares Are Trading Lower After the Company Priced a $500 Million Offering
在該公司定價了5億美元的發行後,細胞內療法的股價走低
Intra-Cellular Therapies Shares Are Trading Lower After the Company Priced a $500 Million Offering
在該公司定價了5億美元的發行後,細胞內療法的股價走低
使用瀏覽器的分享功能,分享給你的好友吧